DGAP-News: Epigenomics AG / Key word(s): Half Year Results 09.08.2017 / 08:45 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG Announces 2017 Second Quarter and Six Months Financial Results – Reimbursement in the United States is a focus of the company as it will have the greatest impact […]
Category: Press Releases
09. August 2017
Epigenomics AG Announces 2017 Second Quarter and Six Months Financial Results
Read more
12. July 2017
Epigenomics AG: Voluntary public takeover offer by Summit Hero Holding not successful
DGAP-News: Epigenomics AG / Key word(s): Offer 12.07.2017 / 13:30 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG: Voluntary public takeover offer by Summit Hero Holding not successful Berlin, July 12, 2017 – Summit Hero Holding GmbH (“bidder”) announced today that, as of expiry of the extended acceptance […]
14. June 2017
Epigenomics AG: Executive Board and Supervisory Board recommend acceptance of the voluntary public takeover offer
DGAP-News: Epigenomics AG / Key word(s): Offer 14.06.2017 / 08:55 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG: Executive Board and Supervisory Board recommend acceptance of the voluntary public takeover offer Berlin, 14 June 2017 – The Executive Board and Supervisory Board of Epigenomics AG (Frankfurt Prime Standard: […]
08. June 2017
Epigenomics AG: Offer document published for the voluntary public takeover offer for Epigenomics AG
DGAP-News: Epigenomics AG / Key word(s): Offer 08.06.2017 / 10:55 The issuer is solely responsible for the content of this announcement. Press release Offer document published for the voluntary public takeover offer for Epigenomics AG Berlin, 8 June 2017 – Today Summit Hero Holding GmbH published the offer document for the voluntary takeover offer for […]
31. May 2017
Epigenomics’ Annual General Meeting: CEO touts takeover offer
DGAP-Media / 31.05.2017 / 13:24 Press release Epigenomics’ Annual General Meeting: CEO touts takeover offer – Takeover offer is in the best interests of Epigenomics and its shareholders – Shareholders approved all agenda items according to the Board’s proposal Berlin, 31 May 2017 – The speech from Greg Hamilton, CEO of Epigenomics AG (Frankfurt Prime […]
10. May 2017
Epigenomics AG announces 2017 First Quarter Financial Results
DGAP-News: Epigenomics AG / Key word(s): Quarterly / Interim Statement 10.05.2017 / 08:00 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG announces 2017 First Quarter Financial Results Berlin (Germany) and Germantown, MD (U.S.A.), May 10, 2017 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY), or the “Company”, today announced […]